Cargando…

Combatting mucosal melanoma: recent advances and future perspectives

Mucosal melanomas are a rare subtype of melanoma and are associated with a particularly poor prognosis. Due to the rarity of the diagnosis, and the pace with which the management of cutaneous melanoma has evolved over recent years, there is little good evidence to guide management and evidence-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Tyrrell, Helen, Payne, Miranda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240847/
https://www.ncbi.nlm.nih.gov/pubmed/30459941
http://dx.doi.org/10.2217/mmt-2018-0003
_version_ 1783371703414423552
author Tyrrell, Helen
Payne, Miranda
author_facet Tyrrell, Helen
Payne, Miranda
author_sort Tyrrell, Helen
collection PubMed
description Mucosal melanomas are a rare subtype of melanoma and are associated with a particularly poor prognosis. Due to the rarity of the diagnosis, and the pace with which the management of cutaneous melanoma has evolved over recent years, there is little good evidence to guide management and evidence-based clinical guidelines are still in development in the UK. In this review we provide an overview of the management of mucosal melanoma, highlighting the critical differences between cutaneous and mucosal melanomas, before examining recent advances in the systemic treatment of this disease and likely future directions.
format Online
Article
Text
id pubmed-6240847
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-62408472018-11-20 Combatting mucosal melanoma: recent advances and future perspectives Tyrrell, Helen Payne, Miranda Melanoma Manag Review Mucosal melanomas are a rare subtype of melanoma and are associated with a particularly poor prognosis. Due to the rarity of the diagnosis, and the pace with which the management of cutaneous melanoma has evolved over recent years, there is little good evidence to guide management and evidence-based clinical guidelines are still in development in the UK. In this review we provide an overview of the management of mucosal melanoma, highlighting the critical differences between cutaneous and mucosal melanomas, before examining recent advances in the systemic treatment of this disease and likely future directions. Future Medicine Ltd 2018-10-08 /pmc/articles/PMC6240847/ /pubmed/30459941 http://dx.doi.org/10.2217/mmt-2018-0003 Text en © 2018 Miranda J Payne This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Review
Tyrrell, Helen
Payne, Miranda
Combatting mucosal melanoma: recent advances and future perspectives
title Combatting mucosal melanoma: recent advances and future perspectives
title_full Combatting mucosal melanoma: recent advances and future perspectives
title_fullStr Combatting mucosal melanoma: recent advances and future perspectives
title_full_unstemmed Combatting mucosal melanoma: recent advances and future perspectives
title_short Combatting mucosal melanoma: recent advances and future perspectives
title_sort combatting mucosal melanoma: recent advances and future perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240847/
https://www.ncbi.nlm.nih.gov/pubmed/30459941
http://dx.doi.org/10.2217/mmt-2018-0003
work_keys_str_mv AT tyrrellhelen combattingmucosalmelanomarecentadvancesandfutureperspectives
AT paynemiranda combattingmucosalmelanomarecentadvancesandfutureperspectives